Inventor · disambiguated record
Huanyin Li
Also filed as: LI HUANYIN
14 granted patents·4 pending applications·11 citations·filing 2017–2023
85Inventor score
Files withSHENZHEN TARGETRX INC18
Top patents by PatentIndex Score
18 records- 0190US10543199B2Macrocycle and composition comprising thereofSHENZHEN TARGETRX INC·Filed 2017·Granted Jan 28, 2020·4 cites·16 claims
- 0289US11512074B2Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereofSHENZHEN TARGETRX INC·Filed 2019·Granted Nov 29, 2022·3 cites·13 claims
- 0386US10780082B2Macrocycle and composition comprising thereofSHENZHEN TARGETRX INC·Filed 2019·Granted Sep 22, 2020·2 cites·18 claims
- 0482US11267806B2Indazole compound for use in inhibiting kinase activity, composition and application thereofSHENZHEN TARGETRX INC·Filed 2018·Granted Mar 8, 2022·2 cites·22 claims
- 0569US12264151B2Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereofSHENZHEN TARGETRX INC·Filed 2022·Granted Apr 1, 2025·0 cites·15 claims
- 0668US11517561B2Macrocycle and composition comprising thereofSHENZHEN TARGETRX INC·Filed 2020·Granted Dec 6, 2022·0 cites·18 claims
- 0761US2025179027A1Cycloalkyl or heterocyclyl substituted heteroaryl compound, and composition and use thereofSHENZHEN TARGETRX INC·Filed 2023·Application pending·0 cites
- 0859US11459334B2Substituted pyrrolo[2,1-f][1,2,4]triazines as KIT and/or PDGFR-α inhibitorsSHENZHEN TARGETRX INC·Filed 2019·Granted Oct 4, 2022·0 cites·13 claims
- 0958US12077528B2Preparation method for deuterated macrocyclic compoundSHENZHEN TARGETRX INC·Filed 2019·Granted Sep 3, 2024·0 cites·8 claims
- 1056US2022380375A1Substituted aromatic fused ring derivative and composition comprising same, and use thereofSHENZHEN TARGETRX INC·Filed 2022·Application pending·0 cites
- 1155US2023174554A1Solid form of macrocyclic compound, preparation therefor and use thereofSHENZHEN TARGETRX INC·Filed 2021·Application pending·0 cites
- 1251US12312329B2Aminopyrimidine compound used for inhibiting activity of protein kinaseSHENZHEN TARGETRX INC·Filed 2019·Granted May 27, 2025·0 cites·17 claims
- 1350US11147802B2Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereofSHENZHEN TARGETRX INC·Filed 2017·Granted Oct 19, 2021·0 cites·20 claims
- 1449US11267810B2Aminopyrimidine compound and composition comprising same and use thereofSHENZHEN TARGETRX INC·Filed 2018·Granted Mar 8, 2022·0 cites·16 claims
- 1549US11111233B2Amino pyrimidine compound for inhibiting protein tyrosine kinase activitySHENZHEN TARGETRX INC·Filed 2019·Granted Sep 7, 2021·0 cites·11 claims
- 1645US11384069B2Diphenylaminopyrimidine compound for inhibiting kinase activitySHENZHEN TARGETRX INC·Filed 2018·Granted Jul 12, 2022·0 cites·16 claims
- 1745US11254696B2Dianilinopyrimidine compound for inhibiting kinase activitySHENZHEN TARGETRX INC·Filed 2018·Granted Feb 22, 2022·0 cites·15 claims
- 1844US2021009613A1Arylphosphine oxides for inhibiting kinase activitySHENZHEN TARGETRX INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →